(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Cincinnati Children’s Molecular Genetics Laboratory introduces MetaboSeq, our next-generation sequencing panel of 19 genes associated with fatty acid oxidation disorders (FAOD).
MetaboSeq provides a rapid and cost-effective analysis of the most common genetic causes of nonspecific FAOD. The indications for MetaboSeq include:
Sanger sequencing of CPT2, ACADM, ACADVL and SLC22A5, as well as genotyping for the common E510Q mutation in HADHA, is also available when a specific diagnosis is suggested by preliminary biochemical testing.
MetaboSeq 19-gene sequencing panel
MCAD deficiency (ACADM)
CPT2 deficiency (CPT2)
VLCAD deficiency (ACADVL)
LCHAD deficiency (HADHA 1528 G>C genotyping)
Primary carnitine deficiency (SLC22A5)
Insurance preauthorization is available for every test, and we offer both insurance and third-party billing options.
Clinical interpretations are written in conjunction with our nationally recognized pediatric cardiologist, board-certified molecular and medical geneticists and genetic counselors. Each report includes a detailed interpretation of the findings, their clinical significance and clinical recommendations for follow-up.
The Molecular Genetics Laboratory combines state-of-the-art testing with comprehensive interpretation of test results by experts.
We offer a guide for clinicians to comprehensive molecular testing for fatty acid oxidation disorders that includes:
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.